Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BHV-0223
BHV-0223
Biohaven steps up big clinical plans for its reformulated ALS generic — now also aimed at anxiety
Endpoints
Thu, 08/16/18 - 11:06 pm
Biohaven Pharmaceuticals
BHV-0223
anxiety